It is now clear that biofilms in drains represent a significant risk in healthcare facilities because they can lead to numerous infections. Despite this awareness, most healthcare facilities are reluctant to invest in preventive and routine drain maintenance, arguing that they cannot afford the costs of treating biofilms in drains. Ironically, preventive drain maintenance costs are only a fraction of what it costs to treat hospital-acquired infections or epidemics. The challenge is therefore to make it clear that while investing in infection prevention will always involve some expense, this small investment will drastically slash the immense direct and indirect costs of dealing with an outbreak for the entire healthcare system.
| Bioassure is the first and only Health Canada approved process for treating biofilms. This process replaces assumptions and approximations with accurate and measurable results by controlling the bacteria trapped within biofilms in drains to minimize the risk of drain-related infections. |
|---|
The vast majority of infection-related costs pertain to longer hospital stays for patients. These costs include:
Longer hospital stays also create additional indirect costs:
Investing in the prevention of outbreaks and epidemics simply makes good financial and operational sense. It will help to preserve accessibility to hospital care, prevent long hospital stays, and avoid the exorbitant associated costs for the facility and society as a whole.
A good infection prevention program should include:
The cost of treating outbreaks can run in the tens of thousands of dollars per week. Instead of throwing all this money literally out the window, a small fraction of it could be poured preventatively down the drain, where it will go to much better use.
Like what you’re reading?
Get practical, expert-driven advice—sent straight to your inbox